| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
57,641,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.046 - $0.046 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Amarantus Bioscience Holdings is a biopharmaceutical company. Co. owns or has licenses to various product candidates in the biopharmaceutical and diagnostic areas of the healthcare industry. Co. is developing its diagnostic product candidates in the field of neurology, and its therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology and regenerative medicine.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Commissiong Gerald |
CEO |
• • – |
2016-02-01 |
4 |
A |
$0.27 |
$12,000 |
D/D |
45,283 |
100,347 |
|
- |
|
| Harris Robert Lewis |
Director |
– • – |
2015-12-02 |
4 |
B |
$0.48 |
$9,321 |
D/D |
19,500 |
96,070 |
2.39 |
- |
|
| Farrell Robert Edward |
CFO |
• – – |
2015-04-09 |
4 |
B |
$0.05 |
$9,980 |
D/D |
200,000 |
333,333 |
2.74 |
- |
|
| Commissiong Gerald |
CEO |
• • – |
2015-04-08 |
4 |
B |
$0.05 |
$11,516 |
D/D |
240,000 |
8,259,565 |
2.81 |
- |
|
| Rubinfeld Joseph |
Director |
– • – |
2014-12-08 |
4 |
A |
$0.09 |
$9,914 |
D/D |
116,500 |
2,056,500 |
|
- |
|
| Rubinfeld Joseph |
Director |
– • – |
2014-12-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,940,000 |
|
- |
|
| Commissiong Gerald |
CEO |
• • – |
2014-11-20 |
4 |
B |
$0.08 |
$9,936 |
D/D |
130,000 |
8,019,565 |
2.81 |
- |
|
| Farrell Robert Edward |
CFO |
• • – |
2014-11-19 |
4 |
B |
$0.08 |
$10,000 |
D/D |
133,333 |
133,333 |
2.81 |
- |
|
| Harris Robert Lewis |
Director |
– • – |
2014-10-27 |
4 |
A |
$0.08 |
$82,500 |
I/I |
982,143 |
7,733,178 |
|
- |
|
9 Records found
|
1
|
Page 1 of 1 |
|
|
